In the last trading session, 4.36 million Teladoc Health Inc (NYSE:TDOC) shares changed hands as the company’s beta touched 0.90. With the company’s per share price at $9.01 changed hands at -$0.29 or -3.12% during last session, the market valuation stood at $1.54B. TDOC’s last price was a discount, traded about -150.17% off its 52-week high of $22.54. The share price had its 52-week low at $6.76, which suggests the last value was 24.97% up since then. When we look at Teladoc Health Inc’s average trading volume, we note the 10-day average is 4.5 million shares, with the 3-month average coming to 5.94 million.

Analysts gave the Teladoc Health Inc (TDOC) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.61. If we narrow down to specifics, the data shows that 0 out of 19 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 10 recommended TDOC as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. Teladoc Health Inc’s EPS for the current quarter is expected to be -0.27.

Teladoc Health Inc (NYSE:TDOC) trade information

Instantly TDOC was in red as seen at the end of in last trading. With action -5.26%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -58.19%, with the 5-day performance at -5.26% in the red. However, in the 30-day time frame, Teladoc Health Inc (NYSE:TDOC) is 3.92% up. Looking at the short shares, we see there were 27.64 million shares sold at short interest cover period of 4.45 days.

The consensus price target for the stock as assigned by Wall Street analysts is 36, meaning bulls need an upside of 74.97% from its current market value. According to analyst projections, TDOC’s forecast low is 10 with 150 as the target high. To hit the forecast high, the stock’s price needs a -1564.82% plunge from its current level, while the stock would need to soar -10.99% for it to hit the projected low.

Teladoc Health Inc (TDOC) estimates and forecasts

Data shows that the Teladoc Health Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -34.43% over the past 6 months, a -300.00% in annual growth rate that is considerably lower than the industry average of 7.00%. Year-over-year growth is forecast to reach -1.90% down from the last financial year.

Consensus estimates given by 23 financial analysts project the company’s revenue in the current quarter to hit an average of 631.16M. 23 analysts are of the opinion that Teladoc Health Inc’s revenue for the current quarter will be 633.02M. The company’s revenue for the corresponding quarters a year ago was 664.11M and 660.53M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -5.00%. The estimates for the next quarter sales put growth at -4.20%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 1.91%. The 2024 estimates are for Teladoc Health Inc earnings to decrease by -334.67%.

TDOC Dividends

Teladoc Health Inc is expected to release its next quarterly earnings report in November.

Teladoc Health Inc (NYSE:TDOC)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 0.82% of Teladoc Health Inc shares while 83.58% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 84.27%. There are 83.58% institutions holding the Teladoc Health Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 12.8843% of the shares, roughly 21.61 million TDOC shares worth $211.35 million.

VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.2643% or 17.22 million shares worth $168.38 million as of 2024-06-30.